{{ item.label }}: {{ item.title }}

A Practical Guide to Effective Deprescribing in Mental Health

Wed, 18 Sep 2024

Virtual, Online

Follow the conference on X #DeprescribingMH

This conference focuses on optimising and improving deprescribing in mental health services as outlined in the NHS England Framework for action for integrated care boards (ICBs) and primary care.

The conference will explore the latest developments and guidance in deprescribing, including practical case studies from various trusts and initiatives. We will look at alternatives to pharmacological interventions, recovery from sleeping tablets and tranquilisers, and deprescribing in older people, followed by a panel discussion with leading experts in these areas.

Join us as we engage with leading experts who will share insights and success stories, as well as the potential future of deprescribing in mental health.

“The prescribing numbers for antidepressants have been consistently trending upwards in recent years. Clinicians treating someone who is taking them should regularly review whether they are still providing benefits or might no longer be needed. They should also inform the patient about the advantages and risks of reducing their dose so that they can take part in the decision-making process. It is important to note that, for many patients, antidepressants are part of a lifesaving treatment programme. Patients should not stop taking antidepressants suddenly and should talk to their doctor beforehand. ”

Dr Adrian James, president of the Royal College of Psychiatrists, January 2023

“Prescribing and deprescribing decisions should be made jointly with the patient; their informed consent needs to be obtained and appropriate information on the risks and benefits of using the medicines given. A shared decision-making approach will help manage patients’ expectations about managing their pain and other symptoms. ”

Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care, January 2023

This conference will enable you to:

  • Network with colleagues who are working to improve patient cantered care in mental health deprescribing

  • Learn from outstanding practice in deprescribing from antidepressants

  • Reflect on lived experience

  • Understand current statistics in prescription psychotropics and the challenges in implementing deprescribing guidelines in clinical practice

  • Reflect on national developments and learning

  • Develop and support your staff to deprescribing effectively

  • Implement strategies to minimise risks during the deprescribing process

  • Reflect on the NHS England Framework for action for integrated care boards (ICBs) and primary care

  • Develop your skills in ensuring prescribing/deprescribing decisions are made jointly with the patient

  • Explore the evidence from case studies in alternatives to pharmacological interventions and appropriately commissioned services

  • Understand how new initiatives are supporting deprescribing from long-term antidepressants in Primary Care

  • Identify key strategies for managing co-morbidity and the reality of living with mental and physical illness

  • Understand the priority areas for quality improvement for the care of adult with depression

  • Reflect on the management reducing drug withdrawal symptoms deprescribing in older people

  • Learn from best practice and success stories in supporting people struggling with benzodiazepines and other Z drugs

  • Self assess and reflect on your own practice

  • Supports CPD professional development and acts as revalidation evidence. This course provides 5 Hrs training for CPD subject to peer group approval for revalidation purposes

Speakers include:

Ms Aleksandra Howell

Senior Clinical Pharmacist
Clinical Lead at the West of England AHSN
Oxford University Hospitals NHS Foundation Trust

Dr Toby Pillinger

Clinical Research Fellow
South London & Maudsley NHS Foundation Trust

Jo Pope

Primary Care Network
Aneurin Bevan University Health Board

Exhibition & Sponsorship Packages

This conference offers a valuable opportunity for industry suppliers to personally meet with their target audience where they will have time to talk and demonstrate the benefits of their products. High quality specialist audiences make having a presence at our events a highly targeted and cost effective marketing channel.

Why Exhibit?

Having a presence at this event will give you the opportunity to:

  • Demonstrate your product, system or service
  • Network and engage with your key audience  
  • Generate new business leads
  • Gain exposure for your brand and raise the profile of your organisation
  • Understand the current needs of your audience and challenges they’re facing
  • Update your knowledge of national policy and local developments  

Enquire

Contact Sarah Jane for exhibition and sponsorship prices, or to discuss a tailored package to suit your needs and budget.

Fee Options

Virtual NHS, Schools, Care and Public Sector

£295.00

(£354.00)

Virtual Voluntary sector & charities

£250.00

(£300.00)

Virtual Commercial organisations

£495.00

(£594.00)

(Prices in brackets include VAT)

Discounts

Additional delegate discount:

A discount of 15% will be applied to fees for any extra delegates.

Online discount:

A discount of 10% will be applied if you pay using the website.

Also of Interest

Browser unsupported

You’re using an unsupported browser.

This website uses the latest web technology and your browser doesn't support those technologies at this time.

Please update to Chrome, Firefox, Edge or Safari (on Mac) to view the full experience.